Overview
QTTB market data
Price History
QTTB price chart
Valuation & Profitability
- P/E (TTM)
- 15.60 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.42 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.26 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $1.57 – $23.57 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $465.2 · P/B 8.38 · P/S 8.66.
Company News
Twilio To Rally Around 26%? Here Are 10 Top Analyst Forecasts For TuesdayBenzinga · Jul 28, 2026, 12:19 PM
HC Wainwright & Co. Maintains Buy on Q32 Bio, Raises Price Target to $36Benzinga · Jul 28, 2026, 10:05 AM
Q32 Bio Files Prospectus For Offer And Resale Of 6.875M Shares By Selling StockholdersBenzinga · Jul 17, 2026, 8:36 PM
8-K filing — Q32 Bio Inc. (QTTB)SEC EDGAR · Jul 15, 2026, 9:18 PM
Why Is Q32 Bio Stock Falling Wednesday?Benzinga · Jul 15, 2026, 4:40 PM
Reported Earlier, Q32 Bio Announces $200M Offering, Including 6,027,399 Common Shares At $18.25 Each And Pre-Funded Warrants For 4,931,506 Shares At $18.2499Benzinga · Jul 15, 2026, 6:57 AM
Q32 Bio shares are trading lower after the company announced a $200 million public offering of shares and warrants.Benzinga · Jul 14, 2026, 6:19 PM
Ericsson, Q32 Bio And Other Big Stocks Moving Lower In Tuesday’s Pre-Market SessionBenzinga · Jul 14, 2026, 12:03 PM
Q32 Bio Launches $200M Public Offering Of Its Common StockBenzinga · Jul 13, 2026, 8:02 PM
Wells Fargo Upgrades Q32 Bio to Overweight, Announces $66 Price TargetBenzinga · Jul 13, 2026, 7:00 PM